Literature DB >> 31358578

Evaluation of the Gradient Concentration Strip Method for Antifungal Susceptibility Testing of Isavuconazole and Comparators for Mucorales Species.

Pauline Vidal1,2, Patrick Schwarz3,4, Eric Dannaoui5,6,7.   

Abstract

MIC values for amphotericin B and three azoles determined by the EUCAST reference technique and by gradient concentration strips were compared for 30 Mucorales isolates belonging to clinically important species. Essential agreement (EA) within ±2 dilution steps at 24 hours between the techniques was 83.3% for isavuconazole. EAs for itraconazole, amphotericin B, and posaconazole were 86.7%, 73.3%, and 56.7%, respectively. A good agreement was obtained between visual and spectrophotometric readings for EUCAST.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  EUCAST; Etest; Mucoraleszzm321990; antifungal agents; antifungal susceptibility testing; filamentous fungi

Mesh:

Substances:

Year:  2019        PMID: 31358578      PMCID: PMC6761560          DOI: 10.1128/AAC.00838-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.

Authors:  Maria Drogari-Apiranthitou; Foteini-Despina Mantopoulou; Anna Skiada; Lambrini Kanioura; Maria Grammatikou; Georgia Vrioni; Aggeliki Mitroussia-Ziouva; Athanassios Tsakris; George Petrikkos
Journal:  J Antimicrob Chemother       Date:  2012-04-25       Impact factor: 5.790

Review 3.  In vitro activity of antifungals against Zygomycetes.

Authors:  A Alastruey-Izquierdo; M V Castelli; I Cuesta; O Zaragoza; A Monzón; E Mellado; J L Rodríguez-Tudela
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

4.  Etest cannot be recommended for in vitro susceptibility testing of mucorales.

Authors:  Rita Caramalho; Elisabeth Maurer; Ulrike Binder; Ricardo Araújo; Somayeh Dolatabadi; Cornelia Lass-Flörl; Michaela Lackner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 5.  Antifungal resistance in mucorales.

Authors:  E Dannaoui
Journal:  Int J Antimicrob Agents       Date:  2017-08-09       Impact factor: 5.283

Review 6.  Epidemiology of mucormycosis in Europe.

Authors:  G Petrikkos; A Skiada; M Drogari-Apiranthitou
Journal:  Clin Microbiol Infect       Date:  2014-03-06       Impact factor: 8.067

7.  Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus).

Authors:  Ana Alastruey-Izquierdo; Kerstin Hoffmann; G Sybren de Hoog; Juan Luis Rodriguez-Tudela; Kerstin Voigt; Evangelia Bibashi; Grit Walther
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

8.  Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.

Authors:  A Szekely; E M Johnson; D W Warnock
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  Molecular identification of zygomycetes from culture and experimentally infected tissues.

Authors:  Patrick Schwarz; Stéphane Bretagne; Jean-Charles Gantier; Dea Garcia-Hermoso; Olivier Lortholary; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

10.  In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.

Authors:  Jesús Guinea; Teresa Peláez; Sandra Recio; Marta Torres-Narbona; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.